DAFNA Capital Management’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-5,000
| Closed | -$199K | – | 84 |
|
|
2019
Q3 | $199K | Sell |
5,000
-5,638
| -53% | -$224K | 0.07% | 83 |
|
|
2019
Q2 | $357K | Hold |
10,638
| – | – | 0.13% | 76 |
|
|
2019
Q1 | $564K | Hold |
10,638
| – | – | 0.24% | 63 |
|
|
2018
Q4 | $500K | Hold |
10,638
| – | – | 0.25% | 58 |
|
|
2018
Q3 | $936K | Hold |
10,638
| – | – | 0.38% | 53 |
|
|
2018
Q2 | $1.11M | Buy |
10,638
+9,481
| +819% | +$986K | 0.52% | 48 |
|
|
2018
Q1 | $93K | Sell |
1,157
-9,663
| -89% | -$777K | 0.05% | 71 |
|
|
2017
Q4 | $1.47M | Buy |
10,820
+397
| +4% | +$54K | 0.79% | 39 |
|
|
2017
Q3 | $1.69M | Hold |
10,423
| – | – | 1.05% | 29 |
|
|
2017
Q2 | $1.56M | Hold |
10,423
| – | – | 1.12% | 32 |
|
|
2017
Q1 | $1.63M | Buy |
10,423
+2,427
| +30% | +$379K | 1.38% | 26 |
|
|
2016
Q4 | $1.66M | Buy |
+7,996
| New | +$1.66M | 1.46% | 27 |
|